US BANCORP \DE\ - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 87 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q1 2021$11,000
-21.4%
3,0000.0%0.00%
Q4 2020$14,000
-72.5%
3,0000.0%0.00%
Q3 2020$51,000
+82.1%
3,000
+20.0%
0.00%
Q2 2020$28,000
+133.3%
2,5000.0%0.00%
Q1 2020$12,000
+1100.0%
2,500
+809.1%
0.00%
Q4 2019$1,0000.0%2750.0%0.00%
Q3 2019$1,0000.0%2750.0%0.00%
Q2 2019$1,0000.0%2750.0%0.00%
Q1 2019$1,0000.0%2750.0%0.00%
Q4 2018$1,0000.0%2750.0%0.00%
Q3 2018$1,0000.0%2750.0%0.00%
Q2 2018$1,0000.0%2750.0%0.00%
Q1 2018$1,0000.0%2750.0%0.00%
Q4 2017$1,0000.0%2750.0%0.00%
Q3 2017$1,0000.0%2750.0%0.00%
Q2 2017$1,0000.0%2750.0%0.00%
Q1 2017$1,0000.0%2750.0%0.00%
Q4 2016$1,0000.0%2750.0%0.00%
Q3 2016$1,0000.0%2750.0%0.00%
Q2 2016$1,0000.0%2750.0%0.00%
Q1 2016$1,0000.0%2750.0%0.00%
Q4 2015$1,0000.0%2750.0%0.00%
Q3 2015$1,0000.0%2750.0%0.00%
Q2 2015$1,0000.0%2750.0%0.00%
Q1 2015$1,0000.0%2750.0%0.00%
Q4 2014$1,0002750.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2020
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders